Clinical Trials Directory

Trials / Completed

CompletedNCT02340689

Primary Hyperoxaluria Mutation Genotyping/Phenotyping

Genetic Characterization and Genotype/Phenotype Correlations in Primary Hyperoxaluria

Status
Completed
Phase
Study type
Observational
Enrollment
1,235 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
1 Day
Healthy volunteers
Not accepted

Summary

Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff.

Detailed description

During your study visit, we will draw one tube, about two teaspoons (1 to 1 ½ teaspoons for children), of blood from your arm. White blood cells from the sample will be used as a source of DNA for genetic testing. We will use the DNA to try to identify mutations (changes) in one of the genes that can cause primary hyperoxaluria. This will be done by comparing it with the structure of these genes in normal individuals, patients with primary hyperoxaluria, and family members of primary hyperoxaluria patients. In family members of primary hyperoxaluria patients, a 24 hr urine test may also be collected.

Conditions

Interventions

TypeNameDescription
OTHERGenetic AnalysisWe will draw one tube of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic analysis.

Timeline

Start date
2013-10-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2015-01-19
Last updated
2019-08-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02340689. Inclusion in this directory is not an endorsement.